Handayuan (adalimumab biosimilar) / Fosun Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Handayuan (adalimumab biosimilar) / Fosun Pharma, Getz Pharma
NCT03357939: Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects

Completed
1
220
RoW
HLX03, adalimumab biosimilar, adalimumab, Humira
Shanghai Henlius Biotech
Immune System Disorder
09/18
09/18

Download Options